US Stock MarketDetailed Quotes
APDN Applied DNA Sciences
- 0.191
- -0.002-1.19%
Close Nov 8 16:00 ET
- 0.188
- -0.003-1.73%
Post 19:50 ET
9.64MMarket Cap-25P/E (TTM)
0.193High0.176Low2.62MVolume0.190Open0.193Pre Close483.20KTurnover5.29%Turnover RatioLossP/E (Static)50.48MShares22.80052wk High0.78P/B9.44MFloat Cap0.17252wk Low--Dividend TTM49.47MShs Float719999.520Historical High--Div YieldTTM8.59%Amplitude0.172Historical Low0.184Avg Price1Lot Size
Applied DNA Sciences Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -155.24%-3.49M | -1,597.28%-3.21M | -57.68%-3.76M | 30.74%-6.22M | 17.76%-2.68M | 21.95%-1.37M | 181.86%214.39K | 35.62%-2.38M | 32.95%-8.98M | 30.85%-3.26M |
| Net income from continuing operations | 159.39%1.85M | -915.31%-4.49M | 70.60%-1.13M | -21.20%-10.02M | -444.07%-3.62M | -176.87%-3.11M | 131.32%551.18K | 18.57%-3.84M | 42.08%-8.27M | 85.26%-664.55K |
| Operating gains losses | -2,180.89%-5.79M | 127.56%895.97K | -200.28%-2.64M | 88.38%-860.48K | 89.32%-519.7K | 115.83%278.4K | ---3.25M | --2.63M | -747.83%-7.41M | -2,431.25%-4.87M |
| Depreciation and amortization | -61.57%134.16K | -45.91%186.33K | -11.79%298.95K | 5.56%1.36M | 0.61%329.68K | 8.71%349.15K | 7.37%344.5K | 5.66%338.92K | 52.82%1.29M | 9.27%327.68K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.67M | ---- |
| Change In working capital | -151.18%-348.66K | -98.68%30.5K | 52.17%-628.05K | 156.31%2.45M | 401.01%767.6K | 27.43%681.25K | 37.02%2.31M | -29.81%-1.31M | 126.40%954.57K | 84.00%-255K |
| -Change in receivables | -108.40%-105.02K | -97.99%41.9K | 71.94%-195.25K | 672.48%3.05M | 187.68%410.39K | 561.30%1.25M | 64.30%2.09M | 34.55%-695.91K | 79.80%-532.96K | 77.60%-468.03K |
| -Change in inventory | -249.37%-133.93K | -62.73%41.35K | -137.74%-47.26K | -64.54%272.22K | -12.60%-53.61K | 0.37%89.66K | -83.11%110.93K | 80.70%125.23K | 187.98%767.69K | 94.94%-47.61K |
| -Change in prepaid assets | -76.95%53.86K | -125.39%-67.33K | -110.28%-13.71K | 255.67%767.81K | 23.08%135.66K | -2.10%233.63K | 132.42%265.15K | 649.59%133.37K | -1,721.63%-493.22K | 151.88%110.22K |
| -Change in payables and accrued expense | 81.53%-163.57K | 132.03%51.32K | 34.60%-383.42K | -245.23%-1.35M | -18.46%280.6K | -875.52%-885.47K | -124.95%-160.26K | -244.86%-586.24K | 882.46%930.5K | -78.76%344.12K |
| -Change in other working capital | --0 | -490.20%-36.75K | 104.00%11.6K | -203.74%-293.12K | 97.19%-5.45K | -102.04%-7.41K | 114.74%9.42K | -264.09%-289.68K | 222.83%282.56K | -787.07%-193.71K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -155.24%-3.49M | -1,597.28%-3.21M | -57.68%-3.76M | 30.74%-6.22M | 17.76%-2.68M | 21.95%-1.37M | 181.86%214.39K | 35.62%-2.38M | 32.95%-8.98M | 30.85%-3.26M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 86.51%-21.83K | 72.71%-14.83K | 0 | -123.84%-1.1M | -281.05%-924.67K | -111.02%-161.8K | 17.08%-54.34K | 142.99%45K | 80.79%-489.55K | 73.23%-242.66K |
| Net PPE purchase and sale | 9.80%-21.83K | 72.71%-14.83K | --0 | 93.17%-33.45K | 100.04%87 | 68.44%-24.2K | 17.08%-54.34K | 142.99%45K | 80.79%-489.55K | 73.23%-242.66K |
| Net business purchase and sale | ---- | ---- | ---- | ---1.06M | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 86.51%-21.83K | 72.71%-14.83K | --0 | -123.84%-1.1M | -281.05%-924.67K | -111.02%-161.8K | 17.08%-54.34K | 142.99%45K | 80.79%-489.55K | 73.23%-242.66K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 10.81M | 3.02M | -35.08K | 0 | 0 | 0 | 0 | 0 | 23.27%18.13M | 14.03M |
| Net common stock issuance | --10.81M | --2.93M | --45.57K | --0 | --0 | --0 | --0 | --0 | 4.87%14.43M | --10.33M |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 41.55%3.7M | --3.7M |
| Net other financing activities | ---- | ---- | ---80.64K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --10.81M | --3.02M | ---35.08K | --0 | --0 | --0 | --0 | --0 | 23.27%18.13M | --14.03M |
| Net cash flow | ||||||||||
| Beginning cash position | -70.09%3.9M | -68.09%4.11M | -48.07%7.9M | 132.12%15.22M | 145.76%11.51M | 100.18%13.04M | 368.54%12.88M | 132.12%15.22M | -15.82%6.55M | -61.54%4.68M |
| Current changes in cash | 576.32%7.29M | -230.84%-209.41K | -62.21%-3.79M | -184.45%-7.31M | -134.22%-3.6M | 16.38%-1.53M | -95.75%160.05K | 38.58%-2.34M | 803.07%8.66M | 287.48%10.53M |
| End cash Position | -2.73%11.19M | -70.09%3.9M | -68.09%4.11M | -48.07%7.9M | -48.07%7.9M | 145.76%11.51M | 100.18%13.04M | 368.54%12.88M | 132.12%15.22M | 132.12%15.22M |
| Free cash flow | -129.69%-3.52M | -2,114.90%-3.22M | -57.68%-3.76M | 33.49%-6.3M | 27.40%-2.54M | 16.38%-1.53M | 148.88%160.05K | 37.40%-2.38M | 40.60%-9.47M | 37.68%-3.5M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
